The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

Objectives. To determine the relationship between fecal calprotectin (FCAL) and imaging studies and other biochemical inflammatory markers and the impact of FCAL measurements on decision-making in IBD patient management in usual clinical practice. Methods. 240 persons with IBD were enrolled. The cor...

Full description

Saved in:

Bibliographic Details
Main Authors:	Esmail Abej, Wael El-Matary, Harminder Singh, Charles N. Bernstein
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2016/2483261
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review
by: Bashaar Alibrahim, et al.
Published: (2015-01-01)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
by: Saranya Kittanakom, et al.
Published: (2017-01-01)

Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease
by: Brian Bressler, et al.
Published: (2015-01-01)

The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
by: Laura Chisick, et al.
Published: (2013-01-01)

Characterization of Inflammatory Bowel Disease in Elderly Patients: A Review of Epidemiology, Current Practices and Outcomes of Current Management Strategies
by: Peter Stepaniuk, et al.
Published: (2015-01-01)

Level of fecal neopterin and calprotectin in asymptomatic and symptomatic norovirus-infected children with malnutrition in Indonesia
by: Anisa Lailatul Fitria, et al.
Published: (2025-04-01)

Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01)

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
by: Vendel Kristensen, et al.
Published: (2017-01-01)

Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein, et al.
Published: (1993-01-01)

Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019-01-01)

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain
by: Stanisław Pieczarkowski, et al.
Published: (2016-01-01)

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease
by: Yao Wei, et al.
Published: (2015-01-01)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
by: Nergiz Bayrakci, et al.
Published: (2022-01-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Percutaneous Endoscopic Gastrostomy in Children
by: Wael El-Matary
Published: (2008-01-01)

World Perspectives: The OMGE Database for Inflammatory Bowel Disease
by: De Dombal F Timothy
Published: (1993-01-01)

Predictors of Medication Adherence in Pediatric Inflammatory Bowel Disease Patients at the Stollery Children’s Hospital
by: L Kitney, et al.
Published: (2009-01-01)

The current standard of care of inflammatory bowel disease
by: J Wright
Published: (2024-03-01)

Real World Experience: Impact of a Specialist Interstitial Lung Disease Nurse on Health Care Utilization
by: Onofre Morán-Mendoza, et al.
Published: (2025-04-01)

Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis
by: Lidia Decembrino, et al.
Published: (2015-01-01)

Serum calprotectin in nonsegmental vitiligo: a possible marker of disease activity
by: Dalia A. Bassiouny, et al.
Published: (2025-01-01)

Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice
by: A. A. Sheptulin, et al.
Published: (2023-05-01)

Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01)

Pyogenic Granuloma: An Unusual Cause of Massive Gastrointestinal Bleeding from the Small Bowel
by: Dana C Moffatt, et al.
Published: (2009-01-01)

Survey of Perceptions and Practices among Canadian Gastroenterologists regarding the Prevention of Venous Thromboembolism for Hospitalized Inflammatory Bowel Disease Patients
by: Roshan Razik, et al.
Published: (2012-01-01)

Sexual Abuse in Irritable Bowel Syndrome: To Ask or Not to Ask – That Is the Question
by: Alexandra Ilnyckyj, et al.
Published: (2002-01-01)

Celiac Disease Presenting as Fever of Unknown Origin
by: Megan J. Cooney, et al.
Published: (2013-01-01)

Effect of a single rectal fecal microbiota transplantation on clinical severity and fecal microbial communities in dogs with chronic inflammatory enteropathy
by: Jorge Pérez‐Accino, et al.
Published: (2025-01-01)

The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System
by: Lee Stern, et al.
Published: (2017-01-01)

Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
by: Mark S Silverberg, et al.
Published: (2005-01-01)

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
by: Fang Yang, et al.
Published: (2021-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01)

Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01)

Autoimmunity in Inflammatory Bowel Disease
by: Kiron M Das
Published: (1993-01-01)

Cytokines in inflammatory bowel disease
by: P. L. Beck, et al.
Published: (1997-01-01)

Efficacy of 2 L versus 3 L polyethylene glycol in bowel preparation: a real-world study
by: LI Jiaojun, et al.
Published: (2025-02-01)

Should We Establish Standards of Care for Management of Elderly Patients with Inflammatory Bowel Disease?
by: Subrata Ghosh, et al.
Published: (2015-01-01)

Use of Fecal Occult Blood Test in Hospitalized Patients: Survey of Physicians Practicing in a Large Central Canadian Health Region and Canadian Gastroenterologists
by: Stephen Ip, et al.
Published: (2013-01-01)